Atlas Trials

Exploring the Application of 3D Bioprinting for Personalized Treatment in Primary Liver Cancer With Tumor Microenvironment

Clinical trial NCT07437859 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07437859
Sponsor
Peking Union Medical College Hospital
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Primary Liver Cancer
Start date
2025-10-01
Primary completion
2026-10-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.